WHO/PLoS Collection “No Health Without Research”: A Call for Papers
This flagship report from WHO, will focus on research for better health and provide new ideas, innovative thinking, and pragmatic advice for member states on how to strengthen their own health research systems.
CBC Radio One Interview with Dr. Kishor Wasan
Dr. Kishor Wasan speaks to CBC’s Kirk Williams about the challenges in meeting the needs of impoverished countries and funding research for neglected global diseases.
Gates Grand Challenges: Biomarkers Grant Opportunity
The Bill & Melinda Gates Foundation is accepting letters of inquiry for the new grant program Biomarkers for the Diagnosis of Tuberculosis.
Graduate Student Opportunities with MITACS
MITACS ACCELERATE (www.mitacsaccelerate.ca) sees graduate students or Post-Doctoral Fellows undertaking research on-site within Canada with companies to develop new tools and techniques to address high-level industry issues. The intern gains valuable industrial experience and an opportunity to apply their research to address novel issues, whilst the partner gains access to highly trained individuals (the intern and their […]
Grand Challenges Canada – Explorations: Canadian Rising Stars
This program aims to tap into the creativity, knowledge and skills of young Canadian Scientists. The application deadline is March 7th, 2011.
Dr. Michael Hayden – 2011 Canada Gairdner Wightman Award Recipient
The NGDI’s inaugural speaker, Dr. Michael Hayden has been awarded the prestigious 2011 Canada Gairner Wightman Award. Congratulations!
Mini-Symposium on Mycobacterial Research
Following the Keystone Symposium on TB being held here in Vancouver, five internationally known TB researchers are coming to the Child and Family Research Institute on January 20, 2011. Ricardo Manganelli, University of Padova, Italy Wilbert Bitter, VU University Medical Center, Netherlands Sarah Parker, University of Colorado Health Sciences Center, USA Simon Waddell, Brighton & […]
NGDI Associate, Dr. von Dadelszen receives $7M Gates funding for PRE-EMPT
UBC researchers working at the Child & Family Research Institute will test new strategies for the monitoring, prevention, and treatment of pre-eclampsia.
UBC-developed formulation of leishmaniasis drug shown to be stable and effective in tropical temperatures
Visceral Leishmaniasis is a blood-born parasitic disease that afflicts 12 million people worldwide, mainly in developing countries and tropical regions.
Health innovation in sub-Saharan Africa, BMC Int’l Health & Human Rights Supplement
All studies are co-authored by Dr. Peter Singer, McLaughlin-Rotman Centre for Global Health.